{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T10:45:35Z","timestamp":1777632335870,"version":"3.51.4"},"reference-count":21,"publisher":"BMJ","issue":"5","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2023,4,25]]},"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:p>We report a case of a previously healthy man in his 40s who presented with mild SARS-CoV-2 infection (COVID-19) concomitant with acute onset of left third cranial nerve palsy with restricted supraduction, adduction and infraduction. Our patient did not present any history of hypertension, hyperlipidaemia, diabetes mellitus or smoking. The patient recovered spontaneously without any antiviral treatment. To our knowledge, this is the second report of third cranial nerve palsy spontaneously resolved without any risk factors of vascular disease, specific image findings, nor any possible causes other than COVID-19. In addition, we reviewed 10 other cases of third cranial nerve palsy associated with COVID-19, which suggested that the aetiology varies greatly. As a clinician, it is important to recognise COVID-19 as a differential diagnosis for third cranial nerve palsy. Finally, we aimed to encapsulate the aetiologies and the prognosis of the third cranial nerve palsy associated with COVID-19.<\/jats:p>","DOI":"10.1136\/bcr-2023-255142","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T11:02:28Z","timestamp":1683111748000},"page":"e255142","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Third cranial nerve palsy due to COVID-19 infection"],"prefix":"10.1136","volume":"16","author":[{"given":"Monika","family":"Iwasaki","sequence":"first","affiliation":[{"name":"Department of General Internal Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2074-646X","authenticated-orcid":false,"given":"Toshinori","family":"Nishizawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiki","family":"Iida","sequence":"additional","affiliation":[{"name":"Department of Emergency and Critical Care Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroko","family":"Arioka","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine, St. Luke's International Hospital, Chuo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2023,5,3]]},"reference":[{"key":"2025082801211344000_16.5.e255142.1","unstructured":"WHO . WHO Coronavirus (COVID-19) Dashboard. Geneva: World Health Organization, 2017. Available: https:\/\/covid19.who.int\/"},{"key":"2025082801211344000_16.5.e255142.2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"key":"2025082801211344000_16.5.e255142.3","article-title":"Third cranial nerve palsy due to COVID-19 infection","volume":"13","author":"Douedi","year":"2021","journal-title":"Cureus"},{"key":"2025082801211344000_16.5.e255142.4","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.925897","article-title":"Third cranial nerve palsy presenting with unilateral diplopia and strabismus in a 24-year-old woman with COVID-19","volume":"21","author":"Belghmaidi","year":"2020","journal-title":"Am J Case Rep"},{"key":"2025082801211344000_16.5.e255142.5","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1007\/s00415-020-09773-9","article-title":"The 2019 novel cornoavirus pneumonia with onset of oculomotor nerve palsy: a case study","volume":"267","author":"Wei","year":"2020","journal-title":"J Neurol"},{"key":"2025082801211344000_16.5.e255142.6","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000009619","article-title":"Author response: Miller Fisher syndrome and polyneuritis cranialis in covid-19","volume":"95","author":"Guti\u00e9rrez-Ortiz","year":"2020","journal-title":"Neurology"},{"key":"2025082801211344000_16.5.e255142.7","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1007\/s00415-020-09987-x","article-title":"Isolated post SARS-cov-2 diplopia","volume":"267","author":"Faucher","year":"2020","journal-title":"J Neurol"},{"key":"2025082801211344000_16.5.e255142.8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.25259\/SNI_401_2021","article-title":"Coronavirus disease 2019 infection and pituitary apoplexy: a causal relation or just a coincidence? A case report and review of the literature","volume":"12","author":"Kamel","year":"2021","journal-title":"Surg Neurol Int"},{"key":"2025082801211344000_16.5.e255142.9","doi-asserted-by":"crossref","first-page":"e286","DOI":"10.1097\/WNO.0000000000001160","article-title":"Cranial nerve III palsy in the setting of COVID-19 infection","volume":"41","author":"Fitzpatrick","year":"2021","journal-title":"J Neuro Ophthalmol"},{"key":"2025082801211344000_16.5.e255142.10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jaapos.2021.02.001","article-title":"Oculomotor nerve palsy in an asymptomatic child with COVID-19","volume":"25","author":"Oliveira","year":"2021","journal-title":"J AAPOS"},{"key":"2025082801211344000_16.5.e255142.11","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1016\/j.jiph.2021.08.007","article-title":"Unilateral diplopia and ptosis in a child with covid-19 revealing third cranial nerve palsy","volume":"14","author":"Elenga","year":"2021","journal-title":"J Infect Public Health"},{"key":"2025082801211344000_16.5.e255142.12","doi-asserted-by":"crossref","first-page":"23247096211058490","DOI":"10.1177\/23247096211058490","article-title":"Superior divisional palsy of the oculomotor nerve as a presenting sign of SARS-cov-2 (COVID-19)","volume":"10","author":"Prajwal","year":"2022","journal-title":"J Investig Med High Impact Case Rep"},{"key":"2025082801211344000_16.5.e255142.13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaophthalmol.2016.4456","article-title":"Incidence and etiologies of acquired third nerve palsy using a population-based method","volume":"135","author":"Fang","year":"2017","journal-title":"JAMA Ophthalmol"},{"key":"2025082801211344000_16.5.e255142.14","doi-asserted-by":"crossref","first-page":"107601","DOI":"10.1016\/j.clineuro.2023.107601","article-title":"COVID-19 and isolated oculomotor nerve palsy: clinical features and outcomes","volume":"225","author":"Tan","year":"2023","journal-title":"Clin Neurol Neurosurg"},{"key":"2025082801211344000_16.5.e255142.15","article-title":"Miller Fisher syndrome in the COVID-19 era-a novel target antigen calls for novel treatment","volume":"13","author":"Kajani","year":"2021","journal-title":"Cureus"},{"key":"2025082801211344000_16.5.e255142.16","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neurol.2020.10.001","article-title":"Neurological manifestations associated with sars-cov-2 and other coronaviruses: a narrative review for clinicians","volume":"177","author":"Maury","year":"2021","journal-title":"Rev Neurol (Paris)"},{"key":"2025082801211344000_16.5.e255142.17","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/jamaneurol.2022.0154","article-title":"Postmortem assessment of olfactory tissue degeneration and microvasculopathy in patients with COVID-19","volume":"79","author":"Ho","year":"2022","journal-title":"JAMA Neurol"},{"key":"2025082801211344000_16.5.e255142.18","doi-asserted-by":"crossref","first-page":"573095","DOI":"10.3389\/fneur.2020.573095","article-title":"The spatial and cell-type distribution of SARS-cov-2 receptor ACE2 in the human and mouse brains","volume":"11","author":"Chen","year":"2020","journal-title":"Front Neurol"},{"key":"2025082801211344000_16.5.e255142.19","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.25728","article-title":"The neuroinvasive potential of SARS-cov2 may play a role in the respiratory failure of COVID-19 patients","volume":"92","author":"Li","year":"2020","journal-title":"J Med Virol"},{"key":"2025082801211344000_16.5.e255142.20","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1021\/acs.jproteome.2c00184","article-title":"Protein expression profile of ACE2 in the normal and COVID-19-affected human brain","volume":"21","author":"Lindskog","year":"2022","journal-title":"J Proteome Res"},{"key":"2025082801211344000_16.5.e255142.21","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A6609"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2023-255142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T08:21:23Z","timestamp":1756369283000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2023-255142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2023,5,3]]},"published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1136\/bcr-2023-255142"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2023-255142","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5]]}}}